Novo Nordisk Operating Expenses 2010-2024 | NVO

Novo Nordisk operating expenses for the twelve months ending June 30, 2024 were $21.258B, a 30.64% increase year-over-year.

  • Novo Nordisk annual operating expenses for 2023 were $18.831B, a 30.19% increase from 2022.
  • Novo Nordisk annual operating expenses for 2022 were $14.464B, a 10.65% increase from 2021.
  • Novo Nordisk annual operating expenses for 2021 were $13.071B, a 17.17% increase from 2020.

Novo Nordisk Operating Expenses 2010-2024 | NVO

  • Novo Nordisk annual operating expenses for 2023 were $18.831B, a 30.19% increase from 2022.
  • Novo Nordisk annual operating expenses for 2022 were $14.464B, a 10.65% increase from 2021.
  • Novo Nordisk annual operating expenses for 2021 were $13.071B, a 17.17% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M